President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...

Jerry Keybl, senior vice-president, Biopharma Products and Strategy, Avantor, discusses innovations in biomanufacturing and ...

President Donald Trump plans to start with a “small tariff” on pharmaceutical imports before ramping duties up to 250% within ...

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...

Pharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the ...

A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...

RFK Jr. announced that the U.S. government’s emergency preparedness agency will no longer fund work on mRNA vaccines ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Ocular Therapeutix, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...

The US initiated a Section 232 investigation on pharmaceutical products in April, purportedly to verify the impact of imports ...